By Matthew Lin and Shaidah Deghan, MSc.
Study Rundown: Asthma is a chronic disease that affects approximately 20% of young children, with the cost of care for these patients between 2005 and 2009 estimated as a little over $10 billion. The association between poor prenatal intake of n-3 LCPUFAs and increased risk of asthma in offspring has been suggested by observational studies, but randomized controlled trials have offered mixed results. In the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), researchers aimed to determine if supplementation of n-3 LCPUFAs in pregnant women during their trimester would reduce the risk of asthma in their offspring up to 5 years of age. The results demonstrated that third trimester n-3 LCPUFA
